Developing innovative treatments designed to improve the everyday lives of women and men
Driving Innovative Research
We aim to develop a targeted approach for diseases of high unmet medical need. Our team is committed to bringing much-needed attention and innovation to women’s health and prostate cancer.
– Lynn Seely, MD, Chief Executive Officer
For too long, patients have suffered in the shadows. We are bringing this issue to the light and fighting for a brighter future."
30 Dec 2019
Myovant Sciences Announces Closing of $400 Million Loan Facility, Repayment of Debt, Board of Director Transitions, and Executive Promotions
25 Nov 2019
Myovant Sciences to Present at the Evercore ISI 2nd Annual HealthCONx Conference on December 3, 2019
19 Nov 2019
Myovant Sciences Announces 97% Response Rate in Positive Phase 3 HERO Study of Once-Daily, Oral Relugolix in Men with Advanced Prostate Cancer